Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HCSG vs CTAS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.56B
5Y Perf.-7.7%
CTAS
Cintas Corporation

Specialty Business Services

IndustrialsNASDAQ • US
Market Cap$68.20B
5Y Perf.+173.2%

HCSG vs CTAS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HCSG logoHCSG
CTAS logoCTAS
IndustryMedical - Care FacilitiesSpecialty Business Services
Market Cap$1.56B$68.20B
Revenue (TTM)$1.84B$10.79B
Net Income (TTM)$59M$1.90B
Gross Margin13.3%50.2%
Operating Margin3.0%23.0%
Forward P/E20.3x34.6x
Total Debt$25M$2.65B
Cash & Equiv.$161M$264M

HCSG vs CTASLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HCSG
CTAS
StockMay 20May 26Return
Healthcare Services… (HCSG)10092.3-7.7%
Cintas Corporation (CTAS)100273.2+173.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: HCSG vs CTAS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CTAS leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Healthcare Services Group, Inc. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HCSG
Healthcare Services Group, Inc.
The Income Pick

HCSG is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 20 yrs, beta 1.12
  • Lower volatility, beta 1.12, Low D/E 4.8%, current ratio 3.38x
  • Lower P/E (20.3x vs 34.6x)
Best for: income & stability and sleep-well-at-night
CTAS
Cintas Corporation
The Growth Play

CTAS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 7.7%, EPS growth 16.1%, 3Y rev CAGR 9.6%
  • 6.9% 10Y total return vs HCSG's -28.2%
  • Beta 0.51, yield 0.9%, current ratio 2.09x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCTAS logoCTAS7.7% revenue growth vs HCSG's 7.1%
ValueHCSG logoHCSGLower P/E (20.3x vs 34.6x)
Quality / MarginsCTAS logoCTAS17.6% margin vs HCSG's 3.2%
Stability / SafetyCTAS logoCTASBeta 0.51 vs HCSG's 1.12
DividendsCTAS logoCTAS0.9% yield; 3-year raise streak; the other pay no meaningful dividend
Momentum (1Y)HCSG logoHCSG+49.1% vs CTAS's -19.3%
Efficiency (ROA)CTAS logoCTAS18.7% ROA vs HCSG's 7.3%, ROIC 25.8% vs 9.0%

HCSG vs CTAS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
CTASCintas Corporation
FY 2025
Uniform Rental and Facility Services
77.1%$8.0B
First Aid and Safety Services
11.8%$1.2B
Fire Protection Services
7.9%$817M
Uniform Direct Sales
3.2%$329M

HCSG vs CTAS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCTASLAGGINGHCSG

Income & Cash Flow (Last 12 Months)

CTAS leads this category, winning 5 of 6 comparable metrics.

CTAS is the larger business by revenue, generating $10.8B annually — 5.9x HCSG's $1.8B. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to HCSG's 3.2%.

MetricHCSG logoHCSGHealthcare Servic…CTAS logoCTASCintas Corporation
RevenueTrailing 12 months$1.8B$10.8B
EBITDAEarnings before interest/tax$72M$2.9B
Net IncomeAfter-tax profit$59M$1.9B
Free Cash FlowCash after capex$139M$1.8B
Gross MarginGross profit ÷ Revenue+13.3%+50.2%
Operating MarginEBIT ÷ Revenue+3.0%+23.0%
Net MarginNet income ÷ Revenue+3.2%+17.6%
FCF MarginFCF ÷ Revenue+7.6%+16.5%
Rev. Growth (YoY)Latest quarter vs prior year+6.6%+9.3%
EPS Growth (YoY)Latest quarter vs prior year+175.0%+11.0%
CTAS leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

HCSG leads this category, winning 6 of 6 comparable metrics.

At 26.8x trailing earnings, HCSG trades at a 30% valuation discount to CTAS's 38.5x P/E. On an enterprise value basis, HCSG's 21.7x EV/EBITDA is more attractive than CTAS's 24.7x.

MetricHCSG logoHCSGHealthcare Servic…CTAS logoCTASCintas Corporation
Market CapShares × price$1.6B$68.2B
Enterprise ValueMkt cap + debt − cash$1.4B$70.6B
Trailing P/EPrice ÷ TTM EPS26.83x38.47x
Forward P/EPrice ÷ next-FY EPS est.20.29x34.59x
PEG RatioP/E ÷ EPS growth rate2.30x
EV / EBITDAEnterprise value multiple21.74x24.73x
Price / SalesMarket cap ÷ Revenue0.85x6.60x
Price / BookPrice ÷ Book value/share3.11x14.82x
Price / FCFMarket cap ÷ FCF11.19x38.82x
HCSG leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

CTAS leads this category, winning 5 of 9 comparable metrics.

CTAS delivers a 42.6% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $12 for HCSG. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to CTAS's 0.57x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs HCSG's 7/9, reflecting strong financial health.

MetricHCSG logoHCSGHealthcare Servic…CTAS logoCTASCintas Corporation
ROE (TTM)Return on equity+11.8%+42.6%
ROA (TTM)Return on assets+7.3%+18.7%
ROICReturn on invested capital+9.0%+25.8%
ROCEReturn on capital employed+7.7%+29.8%
Piotroski ScoreFundamental quality 0–979
Debt / EquityFinancial leverage0.05x0.57x
Net DebtTotal debt minus cash-$136M$2.4B
Cash & Equiv.Liquid assets$161M$264M
Total DebtShort + long-term debt$25M$2.7B
Interest CoverageEBIT ÷ Interest expense33.02x24.61x
CTAS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CTAS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CTAS five years ago would be worth $20,172 today (with dividends reinvested), compared to $7,822 for HCSG. Over the past 12 months, HCSG leads with a +49.1% total return vs CTAS's -19.3%. The 3-year compound annual growth rate (CAGR) favors CTAS at 14.2% vs HCSG's 12.9% — a key indicator of consistent wealth creation.

MetricHCSG logoHCSGHealthcare Servic…CTAS logoCTASCintas Corporation
YTD ReturnYear-to-date+25.2%-8.2%
1-Year ReturnPast 12 months+49.1%-19.3%
3-Year ReturnCumulative with dividends+43.8%+49.1%
5-Year ReturnCumulative with dividends-21.8%+101.7%
10-Year ReturnCumulative with dividends-28.2%+694.8%
CAGR (3Y)Annualised 3-year return+12.9%+14.2%
CTAS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HCSG and CTAS each lead in 1 of 2 comparable metrics.

CTAS is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 89.1% from its 52-week high vs CTAS's 73.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHCSG logoHCSGHealthcare Servic…CTAS logoCTASCintas Corporation
Beta (5Y)Sensitivity to S&P 5001.12x0.51x
52-Week HighHighest price in past year$24.39$229.24
52-Week LowLowest price in past year$12.66$165.46
% of 52W HighCurrent price vs 52-week peak+89.1%+73.8%
RSI (14)Momentum oscillator 0–10055.631.5
Avg Volume (50D)Average daily shares traded684K2.2M
Evenly matched — HCSG and CTAS each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCSG leads this category, winning 1 of 1 comparable metric.

Wall Street rates HCSG as "Hold" and CTAS as "Hold". Consensus price targets imply 32.0% upside for CTAS (target: $223) vs 12.7% for HCSG (target: $25). CTAS is the only dividend payer here at 0.88% yield — a key consideration for income-focused portfolios.

MetricHCSG logoHCSGHealthcare Servic…CTAS logoCTASCintas Corporation
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$24.50$223.40
# AnalystsCovering analysts1530
Dividend YieldAnnual dividend ÷ price+0.9%
Dividend StreakConsecutive years of raises203
Dividend / ShareAnnual DPS$1.49
Buyback YieldShare repurchases ÷ mkt cap+4.0%+1.4%
HCSG leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CTAS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HCSG leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallCintas Corporation (CTAS)Leads 3 of 6 categories
Loading custom metrics...

HCSG vs CTAS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HCSG or CTAS a better buy right now?

For growth investors, Cintas Corporation (CTAS) is the stronger pick with 7.

7% revenue growth year-over-year, versus 7. 1% for Healthcare Services Group, Inc. (HCSG). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 26. 8x trailing P/E (20. 3x forward), making it the more compelling value choice. Analysts rate Healthcare Services Group, Inc. (HCSG) a "Hold" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HCSG or CTAS?

On trailing P/E, Healthcare Services Group, Inc.

(HCSG) is the cheapest at 26. 8x versus Cintas Corporation at 38. 5x. On forward P/E, Healthcare Services Group, Inc. is actually cheaper at 20. 3x.

03

Which is the better long-term investment — HCSG or CTAS?

Over the past 5 years, Cintas Corporation (CTAS) delivered a total return of +101.

7%, compared to -21. 8% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: CTAS returned +694. 8% versus HCSG's -28. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HCSG or CTAS?

By beta (market sensitivity over 5 years), Cintas Corporation (CTAS) is the lower-risk stock at 0.

51β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 121% more volatile than CTAS relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 57% for Cintas Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — HCSG or CTAS?

By revenue growth (latest reported year), Cintas Corporation (CTAS) is pulling ahead at 7.

7% versus 7. 1% for Healthcare Services Group, Inc. (HCSG). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to 16. 1% for Cintas Corporation. Over a 3-year CAGR, CTAS leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HCSG or CTAS?

Cintas Corporation (CTAS) is the more profitable company, earning 17.

5% net margin versus 3. 2% for Healthcare Services Group, Inc. — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HCSG or CTAS more undervalued right now?

On forward earnings alone, Healthcare Services Group, Inc.

(HCSG) trades at 20. 3x forward P/E versus 34. 6x for Cintas Corporation — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTAS: 32. 0% to $223. 40.

08

Which pays a better dividend — HCSG or CTAS?

In this comparison, CTAS (0.

9% yield) pays a dividend. HCSG does not pay a meaningful dividend and should not be held primarily for income.

09

Is HCSG or CTAS better for a retirement portfolio?

For long-horizon retirement investors, Cintas Corporation (CTAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

51), 0. 9% yield, +694. 8% 10Y return). Both have compounded well over 10 years (CTAS: +694. 8%, HCSG: -28. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HCSG and CTAS?

These companies operate in different sectors (HCSG (Healthcare) and CTAS (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

CTAS pays a dividend while HCSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HCSG

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

CTAS

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HCSG and CTAS on the metrics below

Revenue Growth>
%
(HCSG: 6.6% · CTAS: 9.3%)
Net Margin>
%
(HCSG: 3.2% · CTAS: 17.6%)
P/E Ratio<
x
(HCSG: 26.8x · CTAS: 38.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.